VALGANCICLOVIR MYLAN 450 MG TBL FLM 60 I
Rychlý přehled
| Dosage form | Tablets film-coated |
|---|---|
| Výdej | Ne, lék nelze získat bez receptu. |
| Úhrada / doplatek / cena | Ano, zkontrolujte ale specializaci předepisujícího lékaře níže (tzv. nedelegovatelná preskripce). Maximální doplatek: 16 160,78 Kč. Maximální cena: 33 128,26 Kč. |
| Kdo může předepsat | infectious diseases medicineclinical oncology, pediatric oncology and hematology, radiation oncology and oncogynecologyhematology and transfusion medicine, pediatric oncology and hematologyspecial… |
| Složení | Valganciklovir-hydrochlorid (496,3 mg), valganciklovir (450 mg), mikrokrystalická celulosa, krospovidon typ a, kyselina stearová, hypromelosa 2910/3, oxid titaničitý, hypromelosa 2910/6, makrogol 400, červený oxid želez… |
| Dostupnost / výpadek | Ukončeno The latest report from the manufacturer is from 2. 5. 2025. Výroba byla ukončena s platností od 7. 5. 2025. The manufacturer lists medicines with the following code as a potential substitute: 0279398 |
| Kód SÚKL | 0234668 |
What is the maximum co-payment for VALGANCICLOVIR MYLAN?
If the insurance company contributes, the maximum co-payment is 16 160,78 Kč. The maximum pharmacy price is 33 128,26 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.
Does the medicine have reimbursement from public health insurance?
Yes, but check the specialization of the prescribing physician below (a so-called non-delegable prescription).
Does VALGANCICLOVIR MYLAN have a counted co-payment set?
Yes, the medicine has a counted co-payment of 5 867,00 Kč. Learn more about the protective limit here.
How much does the insurance company pay for one dispensed reimbursed pack?
16 967,48 Kč.
Does the insurance company pay a higher amount in some cases?
No, the medicine has no increased reimbursement.
Does the medicine have an indication restriction?
Is it available without a medical prescription?
No, the medicine cannot be obtained without a prescription.
Which medical specialist may prescribe VALGANCICLOVIR MYLAN?
- infectious diseases medicine
- clinical oncology, pediatric oncology and hematology, radiation oncology and oncogynecology
- hematology and transfusion medicine, pediatric oncology and hematology
- specializované pracoviště – transplantační centrum
- pneumology and phthisiology, pediatric pneumology
What is the composition of VALGANCICLOVIR MYLAN?
Valganciklovir-hydrochlorid (496,3 mg), valganciklovir (450 mg), mikrokrystalická celulosa, krospovidon typ a, kyselina stearová, hypromelosa 2910/3, oxid titaničitý, hypromelosa 2910/6, makrogol 400, červený oxid železitý, polysorbát 80. More information about the composition can be found in the SPC, section 6.1.
Where can I find information about correct use of the medicine?
- Documents could not be found
Which medicines are similar to VALGANCICLOVIR MYLAN?
The medicine belongs to ATC group J05AB14 – Valganciklovir. Medicines with the same active substance can be found here.
Who manufactures VALGANCICLOVIR MYLAN?
Informace o výrobci není dostupná.
Is the medicine in shortage?
The latest report from the manufacturer is from 2. 5. 2025. Production was terminated with effect from 7. 5. 2025. The manufacturer lists medicines with the following code as a potential substitute:
What is the unique code for VALGANCICLOVIR MYLAN?
The medicine has code 0234668. Code details can be found here.
How many packs of VALGANCICLOVIR MYLAN were previously dispensed on prescriptions in Czechia?
Show prescription medicine consumption
How many packs of VALGANCICLOVIR MYLAN were previously dispensed on request forms in Czechia?
Show request-form medicine consumption
Z čeho se skládá maximální cena léku?
The page was last updated on 17. 07. 2026